Osteoporosis bisphosphonates for

BRENCKMANN 0 and PAPAIOANNOU A (2001) Bisphosphonates for osteoporosis in people with cystic fibrosis. Cochrane Database Syst Rev. 4 CD002010. 

In a retrospective audit of 105 patients (38 men and 67 women, over 18 years of age) in a tertiary care center in India, 56 % had at least one documented intervention related to osteoporosis prevention (calcium, vitamin D, bisphosphonates, or a bone mineral density study) [17. Only three patients received bisphosphonates for osteoporosis prophylaxis. There was poor pretherapeutic risk assessment, absence of instructions regarding preventive measures, inappropriate investigation for the presence of osteoporosis, and unacceptable failure to use bone protective agents. 

In a retrospective case series of 34 cases of osteonecrosis, bisphosphonates were used in the management of disseminated cancers in 30 patients and four received bisphosphonates for osteoporosis [145]. The most frequently used bisphosphonate was zoledronic acid, in 29 cases. Microbiological data obtained in 25... 

---